CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop advanced computational tools to analyze molecular and clinical data in prostate cancer. By integrating various data types, the goal is to enhance understanding of disease mechanisms and provide personalized treatment recommendations for patients.
Despite of their great promise, high-throughput technologies in cancer research have often failed to translate to major therapeutic advances in the clinic.
One challenge has been tumour heterogeneity, where multiple competing subclones coexist within a single tumour.
Genomic heterogeneity renders it difficult to identify all driving molecular alterations, and thus results in therapies that only target subsets of aggressive tumour cells.
Another challenge lies in the integration of multiple types…
TECHNIKON FORSCHUNGS- UND PLANUNGSGESELLSCHAFT MBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, Rueschlikon
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
TECHNISCHE UNIVERSITAT DARMSTADT
Germany, Darmstadt
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Germany, Aachen
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Switzerland, Zuerich
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
